CEL-SCI Corp CVM

Healthcare Biotechnology

CEL-SCI Corporation is a clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system. The Company is focused on the development of product candidates and technologies, such as Multikine, an investigational immunotherapy under development for the potential treatment of certain head and neck cancers, and Ligand Epitope Antigen Presentation System (LEAPS), with several product candidates under development for the potential treatment of rheumatoid arthritis. Multikine is a biological medicinal immunotherapy comprising a mixture of natural cytokines and small biological molecules. Multikine is injected around the tumor and adjacent lymph nodes for three weeks as a first-line treatment before the standard of care (SOC), which is surgery followed by either radiotherapy or chemoradiotherapy. Multikines rationale for use is to incite a locoregional immune response against the tumor.

NYSEAM:CVM - Post by User

CEL-SCI Corp

Bullboard Posts

Post by GEE3708on Oct 29, 2009 2:17pm

314 Views

Post# 16435948

0.32?

Why do they refer to a 32cent SP? Anyone?
https://www.stockhouse.com/Columnists/2008/October/28/Dividend-and-speculative-stock-

We think the following stocks are bargains, but if we get a real panic sell-off they can get even cheaper, so we would buy half of our allocation here and put in good-till-cancelled orders at prices 50% lower and just wait (prices are as of Friday ): Cincinnati Financial (CINF) 22.23; Dow Chemical (DOW) 23.86; Steel Dynamics (STLD) 9.59; Continental Resources (CLR) 22.49; Peabody Coal (BTU) 29.68; Developers Diversified (DDR) 8.08; Celldex (CLDX) 6.23; and China Direct (CDS) 2.50. But our normal buying strategy is: Buy 40% NOW and 30% more on each 20% decline from the original buy price. We think our penny (which we own) CVM at 32 cents and MDIN at .0002 cents are fantastic gambles at these prices.